NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 254 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,686,185 | -21.6% | 218,389 | +2.5% | 0.01% | -20.0% |
Q2 2023 | $3,425,208 | -1.6% | 213,143 | +6.6% | 0.01% | 0.0% |
Q1 2023 | $3,479,806 | +24.7% | 199,874 | -33.8% | 0.01% | +11.1% |
Q4 2022 | $2,789,574 | +6.2% | 301,902 | -1.0% | 0.01% | +12.5% |
Q3 2022 | $2,626,000 | -3.3% | 304,995 | -8.5% | 0.01% | +14.3% |
Q2 2022 | $2,716,000 | -11.0% | 333,222 | +32.8% | 0.01% | +16.7% |
Q1 2022 | $3,050,000 | -33.8% | 251,000 | +85.8% | 0.01% | -33.3% |
Q4 2021 | $4,610,000 | -29.3% | 135,100 | 0.0% | 0.01% | -30.8% |
Q3 2021 | $6,517,000 | – | 135,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |